CARE Pharmaceuticals and the National Asthma Council Australia have recently renewed their "Sensitive Choice" partnership for the FESS range of products.
The arrangement has been in place since 2012, with the latest extension seeing the "strong and productive relationship" extended through until 2021.
Sensitive Choice is an "independent and credible community service program" created by the National Asthma Council Australia, designed to help Australians identify asthma and allergy-aware products.
A voluntary, independent Sensitive Choice Product Advisory Panel including a pharmacist, chemist, engineer, GP, allergist and respiratory physician assesses each product to determine its suitability to carry the Sensitive Choice logo.
The program was developed in 2006 with partners, including FESS/Care Pharmaceuticals, helping provide funds for all the work and education led by the National Asthma Council to reduce the health, social and economic impacts of asthma and allergies.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Oct 18
